2-70663606-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001617.4(ADD2):c.2000G>A(p.Ser667Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001617.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADD2 | NM_001617.4 | c.2000G>A | p.Ser667Asn | missense_variant | 16/16 | ENST00000264436.9 | NP_001608.1 | |
ADD2 | NM_001185054.2 | c.2000G>A | p.Ser667Asn | missense_variant | 16/16 | NP_001171983.1 | ||
ADD2 | XM_011532502.3 | c.2000G>A | p.Ser667Asn | missense_variant | 16/16 | XP_011530804.1 | ||
ADD2 | NM_017488.4 | c.*154G>A | 3_prime_UTR_variant | 17/17 | NP_059522.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 248996Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134800
GnomAD4 exome AF: 0.000146 AC: 213AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 89AN XY: 727248
GnomAD4 genome AF: 0.000112 AC: 17AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.2000G>A (p.S667N) alteration is located in exon 16 (coding exon 14) of the ADD2 gene. This alteration results from a G to A substitution at nucleotide position 2000, causing the serine (S) at amino acid position 667 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at